A technology-driven end-to-end R&D system and biomanufacturing platform enabling predictable design of raw materials as well as green and efficient mass production
AI-powered R&D platform · Pioneering a new paradigm for ingredient screening, efficacy screening in cell labs, and multi-dimensional efficacy validation
Recently, to further showcase INNOIDUNA's "from medicine to beauty" scientific heritage and skin aesthetics philosophy, the brand launched a premium traceability journey themed "Tracing Granada, Unveiling the Beauty of Rhythm" in Spain. Over two days, the brand collaborated with partners to present an immersive experience blending academic discussions, research visits, and luxury skincare treatments, allowing guests to witness INNOIDUNA's scientific power and rhythmic beauty from lab to skin fir
On June 19, the "Boundless Light, Reborn Universe" INNO Skin Family Gala and INNO MEDISPA Greater China Launch Event concluded successfully at The Seagull Regent Shanghai, a luxury hotel by the Huangpu River. INNO Skin Family Global CEO Fernando Bouffard Fita and the Spanish core team, INNO China founder Yilia, Hongsong Group Chairman Yu Hongzhong, alongside industry leaders, medical experts, and renowned bloggers, gathered to witness a century of heritage, explore the industry's future, and ina
On December 16, 2025, the INNO Skin Family "New Era of Radiance · Pigment Management Summit" concluded successfully at Shanghai Lanyuan. The brand officially released the "2026 Strategy and INNO MEDISPA Standardization Plan," leveraging a century of pharmaceutical expertise, medical-grade product systems, and systematic solutions to redefine industry standards for pigment management. This marks INNO Skin Family's strategic upgrade from "excellent product provider" to "trusted one-stop growth par
